Kodiak Sciences (KOD) Expected to Announce Quarterly Earnings on Thursday

Kodiak Sciences (NASDAQ:KOD) is expected to be announcing its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.87) per share for the quarter.

Kodiak Sciences Stock Performance

Shares of NASDAQ:KOD opened at $3.35 on Thursday. Kodiak Sciences has a 52-week low of $2.19 and a 52-week high of $11.60. The firm has a market capitalization of $176.29 million, a P/E ratio of -0.92 and a beta of 2.26. The stock has a 50 day moving average price of $5.54 and a 200-day moving average price of $5.39.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised Kodiak Sciences from a “hold” rating to a “buy” rating and set a $20.00 price objective for the company in a research report on Monday, December 9th.

About Kodiak Sciences

Kodiak Sciences Inc, a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy.